Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-12 Ho Maykin Director Grant or award · Stock Option (Right to Buy) +7,000 7,000
2025-06-04 Ho Maykin Director Grant or award · Stock Option (Right to Buy) +120,000 120,000
2024-06-05 Ho Maykin Director Grant or award · Stock Option (Right to Buy) +70,000 70,000
2023-06-08 Ho Maykin Director Sale 10b5-1 −2,295 $16.79 $39K 37,726
2023-06-08 Ho Maykin Director Sale 10b5-1 −6,225 $17.68 $110K 31,501
2023-06-07 Ho Maykin Director Grant or award 10b5-1 +8,289 40,021
2023-06-07 Ho Maykin Director Grant or award · Stock Option (Right to Buy) 10b5-1 +12,666 12,666
2022-06-16 Ho Maykin Director Grant or award +15,777 31,732
2022-06-16 Ho Maykin Director Grant or award · Stock Option (Right to Buy) +25,684 25,684
2021-05-26 Ho Maykin Director Grant or award +4,700 15,955
2021-05-26 Ho Maykin Director Grant or award · Stock Option (Right to Buy) +7,800 7,800

Page 1 of 1 · 11 trades